Noninvasive urine exfoliated cell fluorescent staining method

Through non-invasive urine shedding cell fluorescence staining method, combined with acridine orange staining fluorescence microscopy technology, the invasive and hyposensitivity problems in bladder cancer diagnosis are solved, and early, high-sensitivity and high-specific bladder cancer detection is achieved. A fast, accurate and economical screening method.

CN119020447AInactive Publication Date: 2024-11-26JILIN MICRO MOTION MEDICAL TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411057714.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-02
Publication Date
2024-11-26
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing bladder cancer diagnosis methods have problems of invasiveness, pain, hyposensitivity and insufficient specificity, especially in early screening and recurrence testing.

Method used

Using non-invasive urine shedding cell fluorescence staining method, using acridine orange staining fluorescence microscopy technology, the early stage of bladder cancer is improved by optimizing sample collection, cell concentration, smear production, staining and microscopy examination processes, combining cell morphology and chemical characteristics. Detection rate.

Benefits of technology

It significantly improves the detection sensitivity and specificity of bladder cancer, reduces the missed detection rate, and provides a fast, accurate and cost-effective screening method that can identify malignant cells early and reduces the risk of misdiagnosis.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention discloses a non-invasive urine exfoliated cell fluorescent staining method. The method comprises the following steps: (1) collecting urine; urine collection modes comprise a natural urination method, catheterization and bladder irrigation; (2) centrifuging; uniformly shaking all urine specimens, pouring the urine specimens into 4-5 centrifugal tubes, centrifuging for 10 minutes at the rotating speed of 1500r / min, and taking out the test tubes; in conclusion, the method is simple and rapid to operate, sample treatment and analysis can be completed in a short time, rapid diagnosis feedback can be provided, timely treatment is facilitated, normal cells and abnormal cells can be clearly distinguished through the acridine orange staining technology, particularly, the characteristics of early bladder cancer cells can be recognized, and the detection accuracy is improved; the invention plays an important role in early discovery, illness monitoring and prognosis evaluation of bladder cancer, and makes a contribution to improvement of the survival rate and life quality of patients.
Need to check novelty before this filing date? Find Prior Art